Skip to Content

Raffles Medical Group Ltd BSL

Morningstar Rating
SGD 1.01 −0.01 (0.98%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BSL is trading at a 21% discount.
Price
SGD 1.01
Fair Value
SGD 7.19
Uncertainty
High
1-Star Price
SGD 1.52
5-Star Price
SGD 7.94
Economic Moat
Mjhnnp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BSL is a good fit for your portfolio.

Trading Information

Previous Close Price
SGD 1.02
Day Range
SGD 1.001.02
52-Week Range
SGD 0.991.48
Bid/Ask
SGD 1.00 / SGD 1.01
Market Cap
SGD 1.88 Bil
Volume/Avg
3.0 Mil / 1.4 Mil

Key Statistics

Price/Earnings (Normalized)
22.29
Price/Sales
2.72
Dividend Yield (Trailing)
3.73%
Dividend Yield (Forward)
2.35%
Total Yield
4.07%

Company Profile

Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue.
Sector
Healthcare
Industry
Medical Care Facilities
Stock Style Box
Mid Core
Total Number of Employees
2,900

Comparables

Valuation

Metric
BSL
CLHO
523323
Price/Earnings (Normalized)
22.2925.7128.98
Price/Book Value
1.864.105.87
Price/Sales
2.722.543.94
Price/Cash Flow
20.2012.1419.83
Price/Earnings
BSL
CLHO
523323

Financial Strength

Metric
BSL
CLHO
523323
Quick Ratio
1.241.031.11
Current Ratio
1.281.231.23
Interest Coverage
19.049.306.87
Quick Ratio
BSL
CLHO
523323

Profitability

Metric
BSL
CLHO
523323
Return on Assets (Normalized)
6.23%14.33%
Return on Equity (Normalized)
9.40%26.76%
Return on Invested Capital (Normalized)
8.19%20.03%
Return on Assets
BSL
CLHO
523323
See how this stock stacks up to its competitors with Morningstar Investor

Medical Care Facilities Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
HCA
HCA Healthcare IncSflmsynnGbcpbx$83.1 Bil
FSNUY
Fresenius SE & Co KGaA ADRJjppg$16.4 Bil
FSNUF
Fresenius SE & Co KGaAJtssln$16.4 Bil
BDUUY
Bangkok Dusit Medical Services PCL ADRJsfb$12.3 Bil
FMCQF
Fresenius Medical Care AGRwczc$11.9 Bil
FMS
Fresenius Medical Care AG ADRVcrhTshctb$11.9 Bil
DVA
DaVita IncLrffsyxWztgkxm$11.7 Bil
UHS
Universal Health Services Inc Class BWrdkcf$11.2 Bil
THC
Tenet Healthcare CorpHfhjkydWvr$9.5 Bil
AMN
AMN Healthcare Services IncVrrjymjvgSbwtjz$2.2 Bil

Sponsor Center